References
- Farquhar J. W., Claireaux A. E. Familial haemophagocytic reticulosis. Arch. Dis. Child. 1952; 27: 519–25
- Perry M. C., Harrison E. G., Burgert E. O. Familial erythropagocytic lymphohistiocytosis: Report of two cases and clinicopathologic review. Cancer 1976; 38: 209–18
- Hus T. S., Komp D. M. Clinical features of familial histiocytosis. Am. J. Pediatr. Hematol. Oncol. 1981; 3: 61–5
- Shapiro D. N., Hutchinson R. J. Familial histiocytosis in offspring of two pregnancies after artificial insemination. N. Engl. J. Med. 1981; 304: 757–9
- Stark B., Hershko C., Rosen N., et al. Familial hemophagocytic lymphohistiocytosis (FHLH) in Israel. Cancer 1984; 54: 2109–21
- Ansbacher L. E., Singsen B. H., Hosier M. W., et al. Familial erythrophagocytic lymphohistiocytosis: An association with serum lipid abnormalities. J. Pediatr. 1983; 102: 270–3
- Lilleyman J. S. The treatment of familial erythrophagocytic lymphohistiocytosis. Cancer 1980; 46: 468–70
- Ladisch S., Ho W., Matheson D., et al. Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis. Blood 1982; 60: 814–21
- Ambruso D. R., Hays T., Zwartjes W. J., et al. Successful treatment of lymphohistiocytic reticulosis with Epi-podophyllotoxin VP16 213. Cancer 1980; 45: 2516–20
- Janka G. E. Familial hemophagocytic lymphohistiocytosis. Eur. J. Pediatr. 1983; 140: 221–30
- Fischer A., Virelizier J. L., Arenzana-Seisdedos F., et al. Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation. Pediatrics 1985; 76: 263–8
- Becton D. L., Kurtzberg J., Kinney T. R., et al. Treatment of lymphohistiocytic erythrophagocytosis with VP16 and Aziridinylbenzoquinone. Med. Pediatr. Oncol. 1987; 15: 58–61
- Fischer A., Cerf-Bensussan N., Blanche S., et al. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J. Pediatr. 1986; 108: 267–70
- Blume K. G., Forman S. J., O'Donnell M. R., et al. Total body irradiation and high-dose etoposide: A new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 1987; 69: 1015–20
- Kataoka Y., Todo S., Moarioka Y., et al. Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis. Cancer
- Alvarado C. S., Buchanan G. R., Kim T. H., et al. Use of VP16 213 in the treatment of familial erythrophagocytic lymphohistiocytosis. Cancer 1986; 57: 1097–100
- Bekkum D. W. Conditioning regimens for marrow grafting. Semin Haematol 1984; 21: 81–90
- Tutschka P. J., Copelan E. A., Klein J. P. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382–88
- Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304
- Stark B., Cohen I. J., Pecht M., et al. Immunologic dysregulation in a patient with familial hemophagocytic lymphohistiocytosis. Cancer 1987; 60: 2629–36